ResearchWorks Archive

Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49

Show simple item record Casso, Deborah en_US Buist, Diana S. M. en_US Taplin, Stephen en_US 2010-04-21T15:48:04Z 2010-04-21T15:48:04Z 2004 en_US
dc.identifier.citation Casso D, Buist D, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health and Quality of Life Outcomes. 2004;2(1):25. en_US
dc.identifier.other 10.1186/1477-7525-2-25 en_US
dc.identifier.uri en_US
dc.description.abstract Background: The purpose of this report is to examine the correlates of quality of life (QOL) of a well-defined group of long-term breast cancer survivors diagnosed between the ages of 40 and 49. Methods: Women were eligible if they were diagnosed with invasive breast cancer or ductal carcinoma in situ 5 to 10 years before June 30, 1998 and were enrolled at Group Health Cooperative, a health maintenance organization in western Washington State. A questionnaire was mailed to 290 women; 216 were included in this analysis. The questionnaire included standardized measures of QOL [e.g., the Cancer Rehabilitation Evaluation System (CARES-SF) and SF-36] as well as general demographic and medical information. ANOVA and logistic regression were used to estimate correlates of self-reported QOL. Results: The mean age at diagnosis was 44.4 years, and the average time since diagnosis was 7.3 years. Women reported high levels of functioning across several standardized QOL scales; mild impairment was found on the CARES-SF Sexual Scale. The presence of breast-related symptoms at survey, use of adjuvant therapy, having lower income, and type of breast surgery were significantly associated with lower QOL 5 to 10 years post-diagnosis on one or more of the scales. Conclusions: Our results emphasize that younger long-term survivors of breast cancer have a high QOL across several standardized measures. However, the long-term consequences of adjuvant therapy and the management of long-term breast-related symptoms are two areas that may be important for clinicians and women with breast cancer in understanding and optimizing long-term QOL. en_US
dc.description.sponsorship This research was supported by funding by a cooperative agreement from the National Cancer Institute (U01CA63731). Part of Dr. Buist's time was supported by CRTG-03-024-01-CCE, a grant from the American Cancer Society. en_US
dc.language.iso en_US en_US
dc.title Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49 en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ResearchWorks

Advanced Search


My Account